These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 5432229)

  • 21. Calcium inhibition of rat liver catechol-O-methyltransferase.
    Weinshilboum RM; Raymond FA
    Biochem Pharmacol; 1976 Mar; 25(5):573-9. PubMed ID: 8053
    [No Abstract]   [Full Text] [Related]  

  • 22. [Purification and characterization of human placenta S-adenosylmethionine:catechol-O-methyltransferase].
    Gugler R; Knuppen R; Breuer H
    Biochim Biophys Acta; 1970 Oct; 220(1):10-21. PubMed ID: 5472718
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytoplsmic uridine phosphorylase of rat liver. Characterization and kinetics.
    Kraut A; Yamada EW
    J Biol Chem; 1971 Apr; 246(7):2021-30. PubMed ID: 5555559
    [No Abstract]   [Full Text] [Related]  

  • 24. [Transamidinase].
    Methfessel J
    Z Gesamte Inn Med; 1970 Jan; 25(2):80-4. PubMed ID: 5420881
    [No Abstract]   [Full Text] [Related]  

  • 25. Biosynthesis of a mycobacterial lipopolysaccharide. Properties of the polysaccharide methyltransferase.
    Ferguson JA; Ballou CE
    J Biol Chem; 1970 Aug; 245(16):4213-23. PubMed ID: 5503262
    [No Abstract]   [Full Text] [Related]  

  • 26. Catechol O-methyltransferase. 10. 5-Substituted 3-hydroxy-4-methoxybenzoic acids (isovanillic acids) and 5-substituted 3-hydroxy-4-methoxybenzaldehydes (isovanillins) as potential inhibitors.
    Borchardt RT; Huber JA; Houston M
    J Med Chem; 1982 Mar; 25(3):258-63. PubMed ID: 7069704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On some new probable paths of pharmacological action on the regulation of the activity of the cardiovascular system].
    Belen'kiĭ ML
    Vestn Akad Med Nauk SSSR; 1966; 21(4):54-9. PubMed ID: 4387356
    [No Abstract]   [Full Text] [Related]  

  • 28. Synthesis and biological evaluation of a novel series of "ortho-nitrated" inhibitors of catechol-O-methyltransferase.
    Learmonth DA; Bonifácio MJ; Soares-da-Silva P
    J Med Chem; 2005 Dec; 48(25):8070-8. PubMed ID: 16335931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the COMT activity by 1-(3,4,5-trimethoxybenzyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1-(3,5-dimethoxy-4-hydroxybenzyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline in vitro.
    Hattori K; Matsuura M; Shimamoto K
    Jpn J Pharmacol; 1969 Jun; 19(2):287-90. PubMed ID: 5308833
    [No Abstract]   [Full Text] [Related]  

  • 30. Catechol O-methyltransferase. 5. Structure-activity relationships for inhibition by flavonoids.
    Borchardt RT; Huber JA
    J Med Chem; 1975 Jan; 18(1):120-2. PubMed ID: 1109569
    [No Abstract]   [Full Text] [Related]  

  • 31. [Uptake of noradrenaline-H3 by the isolated rat heart. Effect of inhibitors of catechol O-methyl transferase].
    Rapin JR; Cohen Y; Valette G
    C R Seances Soc Biol Fil; 1970; 164(1):92-7. PubMed ID: 4248052
    [No Abstract]   [Full Text] [Related]  

  • 32. Natural inhibitors of the transfer ribonucleic acid methylases.
    Kerr SJ
    Biochemistry; 1970 Feb; 9(3):690-5. PubMed ID: 4313475
    [No Abstract]   [Full Text] [Related]  

  • 33. Isolation and purification of an S-adenosylmethionine: delta 24-sterol methyltransferase from yeast.
    Moore JT; Gaylor JL
    J Biol Chem; 1969 Dec; 244(23):6334-40. PubMed ID: 5354959
    [No Abstract]   [Full Text] [Related]  

  • 34. Catechol-O-methyltransferase. I. An enzymatic assay for cardiac norepinephrine.
    Nikodijevic B; Daly J; Creveling CR
    Biochem Pharmacol; 1969 Jul; 18(7):1577-84. PubMed ID: 5806102
    [No Abstract]   [Full Text] [Related]  

  • 35. Purification and properties of catechol-O-methyltransferase.
    Anderson PJ; D'Ioro A
    Biochem Pharmacol; 1968 Sep; 17(9):1943-9. PubMed ID: 5688277
    [No Abstract]   [Full Text] [Related]  

  • 36. Heterogeneity of N-and O-methyltransferases.
    Axelrod J; Vesell ES
    Mol Pharmacol; 1970 Jan; 6(1):78-84. PubMed ID: 5527525
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of catechol-O-methyltransferase by hydroxybenzenes and related compounds.
    Hattori K; Matsuura M; Fujiwara M; Shimamoto K
    Jpn J Pharmacol; 1969 Jun; 19(2):282-6. PubMed ID: 4905656
    [No Abstract]   [Full Text] [Related]  

  • 38. [Catechol-O-methyltransferase, II. Influence of effectors on the initial velocity pattern].
    Flohé L; Schwabe KP
    Hoppe Seylers Z Physiol Chem; 1972 Mar; 353(3):463-75. PubMed ID: 5028211
    [No Abstract]   [Full Text] [Related]  

  • 39. [Action of catechol O methyltransferase inhibitors on the distribution of norepinephrine-H 3 in rats].
    Rapin JR; Caillard RC; Cohen Y; Valette G
    C R Seances Soc Biol Fil; 1971; 165(1):60-4. PubMed ID: 4257753
    [No Abstract]   [Full Text] [Related]  

  • 40. Expression and characterization of rat soluble catechol-O-methyltransferase fusion protein.
    Bonifácio MJ; Vieira-Coelho MA; Soares-da-Silva P
    Protein Expr Purif; 2001 Oct; 23(1):106-12. PubMed ID: 11570851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.